Cited by 383RNA Research and SplicingRNA regulation and diseaseCancer-related molecular mechanisms research

An ESRP‐regulated splicing programme is abrogated during the epithelial–mesenchymal transition

Open access
Warzecha, Claude C, Jiang, Peng, Amirikian, Karine, Dittmar, Kimberly A, Lu, Hezhe, Shen, Shihao, Guo, Wei, Xing, Yi +1 more·2010·The EMBO Journal

Abstract

Alternative splicing achieves coordinated changes in post-transcriptional gene expression programmes through the activities of diverse RNA-binding proteins. Epithelial splicing regulatory proteins 1 and 2 (ESRP1 and ESRP2) are cell-type-specific regulators of transcripts that switch splicing during the epithelial-mesenchymal transition (EMT). To define a comprehensive programme of alternative splicing that is regulated during the EMT, we identified an extensive ESRP-regulated splicing network of hundreds of alternative splicing events within numerous genes with functions in cell-cell adhesion, polarity, and migration. Loss of this global ESRP-regulated epithelial splicing programme induces the phenotypic changes in cell morphology that are observed during the EMT. Components of this splicing signature provide novel molecular markers that can be used to characterize the EMT. Bioinformatics and experimental approaches revealed a high-affinity ESRP-binding motif and a predictive RNA map that governs their activity. This work establishes the ESRPs as coordinators of a complex alternative splicing network that adds an important post-transcriptional layer to the changes in gene expression that underlie epithelial-mesenchymal transitions during development and disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emboj.2010.195

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ESRPs are a conserved family of epithelial-specific RBPs that exert broad control over many physiological processes, including tissue regeneration and the epithelial-mesenchymal transition (EMT) during development and cancer progression.

    “ESRPs are a conserved family of epithelial-specific RBPs that exert broad control over many physiological processes, including tissue regeneration and the epithelial–mesenchymal transition (EMT) during development and cancer progression (Warzecha et al. 2010; Lu et al. 2013; Bebee et al. 2015; Derham and Kalsotra 2023).”

    From ESRP2–microRNA-122 axis promotes the postnatal onset of liver polyploidization and maturation (2025) · cites this paper as Warzecha et al. 2010

    The Introduction (page unavailable) identifies ESRP1 and ESRP2 as epithelial-specific splicing regulators and reports their downregulation during EMT; the microarray-results section calls them phylogenetically conserved splicing factors. The paper identifies hundreds of ESRP-regulated events and reports EMT-like changes after ESRP knockdown, but our copy does not establish a role for ESRPs in tissue regeneration or directly demonstrate their control of EMT during development or cancer progression. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Warzecha, C. C., Jiang, P., Amirikian, K., Dittmar, K. A., Lu, H., Shen, S., Guo, W., Xing, Y., & Carstens, R. P.
Affiliations
  • University of Pennsylvania (US)
  • University of Iowa (US)
Corresponding author
Carstens, Russ P
Venue
The EMBO Journal
Published
2010-08-13
Volume
29
Issue
19
Pages
3286-3300
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2133735831
Cited by
383
References
4
Citations by year
2026: 12 · 2025: 19 · 2024: 9 · 2023: 16 · 2022: 21 · 2021: 26 · 2020: 27 · 2019: 26 · 2018: 25 · 2017: 26 · 2016: 37 · 2015: 25 · 2014: 21 · 2013: 40 · 2012: 29
FWCI
11.86
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Edward Mallinckrodt, Jr. Foundation
  • National Institutes of Health (GM085146, GM088809)
  • National Human Genome Research Institute (R01HG004634)
  • National Cancer Institute (R01CA093769)
  • National Institute of General Medical Sciences (R01GM085146, T32GM008216, T32 GM08216, R01GM088809)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Keywords
epithelial-mesenchymal transition, alternative splicing, ESRP1, ESRP2, RNA-binding proteins, cell-cell adhesion, cell polarity, cell migration, post-transcriptional regulation
MeSH terms
Binding Sites, Cell Adhesion, Cell Differentiation, Cell Line, Cell Movement, Epithelial Cells, Fluorescent Antibody Technique, Gene Expression Regulation, Humans, Mesoderm, Immunoblotting, RNA-Binding Proteins, Cell Polarity, Alternative Splicing, Computational Biology, Reverse Transcriptase Polymerase Chain Reaction, Electrophoretic Mobility Shift Assay, Vesicular Transport Proteins, Microarray Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review